Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01701856
Brief Title: Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis

First Submitted : September 18, 2012
First Submitted that Met QC Criteria : October 4, 2012
First Posted : October 5, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : January 21, 2014
Last Update Posted : January 22, 2014 (Estimate)